… used to identify all thyroid cancer cases who underwent thyroid surgery between 1998 and
… with papillary thyroid cancer. Data were coded according to the Commission on Cancer …

GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma (DTC)
have been reviewed recently (1) and guidelines for management proposed (2). Yet …

… radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and selective
use in patients with intrathyroidal disease … management of papillary thyroid cancer, with a …

… In other words, this article clearly states that welldifferentiated papillary thyroid cancer does
… that we have treated for thyroid cancer with radioactive iodine after surgery/ There has been …

… In the present report, we describe the clinical course of patients with papillary thyroid
cancer in whom disease recurred after initial therapy with surgery and radioactive iodine (MI) …

… and older and included the following terms: papillary thyroid carcinoma, follicular thyroid
carcinoma, RAI, iodine radio isotopes, thyroid neoplasms, and iodine-131. In addition to these …

… Papillary thyroid cancer (PTC) is a common endocrine malignancy with relatively good
prognosis. Radioactive iodine (RAI) is considered effective for patients with total or nearly total …

… effects of radioactive iodine (RAI) ablation for intermediate-risk papillary thyroid cancer (PTC…
To determine the impact of RAI therapy on disease-specific survival (DSS) in patients with …

… The efficacy of radioactive iodine therapy (RAI) in patients who have an undetectable
thyroglobulin (Tg) level after total thyroidectomy in well-differentiated papillary thyroid cancer (PTC) …

… It remains controversial whether papillary thyroid cancer (PTC) patients with low- to
intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy (TT). We …